DMAC
DiaMedica Therapeutics Inc. · Healthcare
Director Randall Michael Giuffre bought $80K of DiaMedica Therapeutics Inc.
Bought$80,463
$1.20Price
67,228Shares
+32%Stake
What DMAC did for a copier
- $1,000 copied at Thu, Dec 1 close, $1.20
- $1,367
- S&P 500, same days
- −1.9%
Measured over 30 trading days, to the Jan 17 close.
Randall Michael Giuffre's record
3 other buys with 3 months of prices since 2018: on average +0.7% against the S&P 500, and 2 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Nov 29. Filed Thu, Dec 1, 12:11 PM ET, during the session. Returns use the Dec 1 close and the Jan 17 close. Not investment advice.